The St. Louis-based Express Scripts Holding Company (NASDAQ:ESRX) boosted its profit estimates for 2012 as gross margins climbed previous quarter following its April purchase of Medco Health Solutions Inc.
Express Scripts, the biggest United States processor of drug prescriptions, reported in a statement on Tuesday that adjusted earnings for the year would be in the range of $3.60 to $3.75 per share, evaluted against a forecast in May of $3.36 to $3.66.
The company reported that Q2 profit, without costs of the Medco acquisition, was 88 cents, over median forecasts of 82 cents from 22 analysts polled by Bloomberg.
Shares of Express Scripts moved up 7% to settle at $60 in afterhours trading session at 5:38 PM New York time. Shares of the company have surged 25% current year.
Shifting readers focus to broader market, let’s consider market performance of other stocks that significantly affect same sector. Johnson & Johnson (NYSE:JNJ) fell -0.80% to settle at $68.29, Pfizer Inc. (NYSE:PFE) moved down -2.14% to end at $23.74 while McDonald’s Corporation (NYSE:MCD) plunged -0.76% to finish on Tuesday at $89.01.
Dean Foods Company (NYSE:DF) last session volume of 5.81 million shares was higher than its average volume of 4.51 million shares. The stock after opening at $56.68 hit high price of $56.83 and then closed at $56.02 by scoring +0.07%.
DF generated revenue of 47.17 billion in the following twelve months and earned $1.22 billion. The Company showed a positive 2.58% in the net profit margin and as well as in its operating margin which remained 4.93%. Company’s annual sales growth for the past five year was 16.43%.
The DF past twelve months price to sales ratio was 0.96 and price to cash ratio remained 4.71. As far as the returns are concern, the DF return on equity was recorded as +36.12% and increased 11.63% return on investment while its return on asset stayed at 8.03%.
The stock showed weekly downbeat performance of -3.31% which was maintained for the month at +3.05%. Likewise the positive performance for the quarter was recorded as +1.39% and for the year was +20.60% while the YTD performance remained at +25.35%.
DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! QuoteDaddy.com delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with QuoteDaddy.com! CLICK HERE TO START YOUR FREE 30-DAY TRIAL
